+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison of high-dose and low-dose aspirin plus intravenous immunoglobulin in the treatment of Kawasaki syndrome



Comparison of high-dose and low-dose aspirin plus intravenous immunoglobulin in the treatment of Kawasaki syndrome



Clinical Pediatrics 41(8): 597-601



The efficacy of intravenous immunoglobulin (IVIG) in the treatment of Kawasaki syndrome (KS) has been unequivocally established, but questions remain concerning the proper dose of adjunctive aspirin therapy in the treatment of KS. The medical records of 72 children with KS were reviewed. All patients were treated with IVIG; 21 received 400 mg/kg/dose on 4 consecutive days and 51 received 2 g/kg as a single infusion. Seventy patients also received aspirin. Twenty-four of the 70 patients were started on high-dose aspirin (80-100 mg/kg/day) at the time of diagnosis. High-dose aspirin was given for a mean (+/- SE) duration of 6.1+/-0.9 days, then switched to low-dose aspirin (3-5 mg/kg/day). Forty-six of the 70 patients were started on low-dose aspirin at the time of diagnosis and remained on low-dose aspirin for the duration of treatment. Coronary artery abnormalities were present at the time of diagnosis in 12 of 72 patients (17%), including 6 of 6 of patients (100%) with atypical KS and 6 of 66 patients (9%) with typical KS. None of the remaining 60 patients developed coronary artery abnormalities after treatment with IVIG and aspirin. The mean duration of fever after initiation of therapy was 44+/-6 hours in patients treated with IVIG 400 mg/kg/dose on 4 consecutive days and 35+/-5 hours in patients treated with 2 g/kg as a single infusion (p=0.3). The mean duration of fever after the initiation of therapy was 47+/-8 hours in patients treated with high-dose aspirin compared to 34+/-5 hours in patients treated with low-dose aspirin (p=0.13). These preliminary results indicate there is no benefit to high-dose aspirin compared to low-dose aspirin in the treatment of children with KS.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 045592856

Download citation: RISBibTeXText

PMID: 12403377

DOI: 10.1177/000992280204100807


Related references

Comparison of low dose aspirin lda vs high dose aspirin hda as an adjunct to intravenous gamma globulin ivig in the treatment of kawasaki syndrome ks. Pediatric Research 31(4 Part 2): 170A, 1992

Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial. Bmc Pediatrics 18(1): 200, 2018

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?. Korean Circulation Journal 47(2): 179-181, 2017

An elevated value of high mobility group box 1 is a potential marker for poor response to high-dose of intravenous immunoglobulin treatment in patients with Kawasaki syndrome. Pediatric Infectious Disease Journal 28(4): 339-341, 2009

Comparison of high-dose versus low-dose aspirin in the management of Kawasaki disease. Indian Journal of Pediatrics 81(12): 1403, 2014

Treatment of Kawasaki's syndrome with high dose intravenous gammaglobulins. Pediatrie 41(1): 65-69, 1986

Clinical outcomes of initial dexamethasone treatment combined with a single high dose of intravenous immunoglobulin for primary treatment of Kawasaki disease. Yonsei Medical Journal 55(5): 1260-1266, 2014

High dose intravenous aspirin, not low dose intravenous or oral aspirin, inhibits thrombus formation and stabilizes blood flow in experimental coronary vascular injury. Journal Of The American College Of Cardiology. 21(2): 502-510, 1993

Behçet's syndrome treated with high-dose intravenous IgG and low-dose aspirin. Journal of the Royal Society of Medicine 83(10): 652-653, 1990

High dose intravenous aspirin vs low dose intravenous or oral aspirin in experimental coronary vascular injury. Journal of the American College of Cardiology 17(2 Suppl. A): 144A, 1991

Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases. American Journal of Medicine 76(3a): 78-82, 1984

Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin. Journal of the Medical Association of Thailand 85(Suppl. 4): S1121-S1126, 2002

Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin. Journal of the Medical Association of Thailand 85(Suppl. 4): S1121, 2002

Cerebral infarction after high-dose intravenous immunoglobulin therapy for Kawasaki disease. Journal of Pediatrics 148(3): 399-400, 2006

Effectiveness of Medium-Dose Intravenous Immunoglobulin (1 g/kg) in the Treatment of Kawasaki Disease. Korean Circulation Journal 40(2): 81-85, 2010